Mounjaro is the type 2 diabetes brand of tirzepatide, the same molecule Eli Lilly sells for weight management as Zepbound. That one fact explains most of the confusion around its price, because the two brands sit in completely different discount programs even though the drug inside is identical.
This guide covers what a cash payer actually pays for Mounjaro in August 2026: the LillyDirect self-pay price, both tiers of the Mounjaro Savings Card, the published list price, what the pharmacy counter charges without a program, and where Mounjaro and Zepbound diverge. Every figure below was pulled directly from Lilly’s own pricing pages, FDA’s Orange Book, and SingleCare’s live drug page on August 31, 2026.
What Does Mounjaro Cost Without Insurance?
There is no single Mounjaro price. There is a price per route, and the gap between the cheapest and most expensive route is about $1,000 a month.
| Route | Low | Average | High |
|---|---|---|---|
| LillyDirect self-pay (any dose) | $499/mo | $499/mo | $499/mo |
| Savings card, commercial plan covers Mounjaro | $25/mo | $25/mo | $25/mo |
| Savings card, commercial plan excludes Mounjaro | $499/mo | $499/mo | $499/mo |
| Retail pharmacy counter, paying cash | $872/mo | $1,112/mo | $1,519/mo |
| Zepbound (same molecule, weight management) | $299/mo | $449/mo | $699/mo |
Self-pay and savings card figures come from Lilly’s LillyDirect product page and the Mounjaro savings and coverage page. The $1,112 midpoint of the retail row is Lilly’s published list price. The $872 and $1,519 endpoints are SingleCare’s discounted and average retail prices for four 5 mg pens.
LillyDirect self-pay: $499 a month, flat
LillyDirect is Lilly’s own pharmacy, and it is where the uninsured self-pay price lives. As of August 2026 the LillyDirect Mounjaro page lists a self-pay price starting at $499 per month on the single-dose prefilled pen, and it repeats that same $499 figure on all six dose cards: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
That flat structure is unusual and it works in your favor at higher doses. A month means 28 days and four pens, and delivery is free. Unlike Zepbound, Mounjaro has no self-pay single-dose vial option, so the pen is the only self-pay format on offer. FDA’s Orange Book does show Lilly won approval for new multi-dose 2.4 mL Mounjaro presentations on January 7, 2026, so a pen holding four doses may reach the self-pay menu later, but it is not priced there yet.
The Mounjaro Savings Card has two very different tiers
The card is not one offer, it is two, and both require commercial insurance. Reading the terms on Lilly’s savings and coverage page:
- If your commercial plan covers Mounjaro: you may pay as little as $25 for a 1-month, 2-month, or 3-month fill. Savings cap at $150 per 1-month fill, $300 per 2-month fill, or $450 per 3-month fill, with a separate annual cap of $1,950 and a maximum of 13 fills per calendar year.
- If your commercial plan does not cover Mounjaro: you may pay as low as $499 for a 1-month fill, with savings capped at $647 per month and $8,411 per calendar year.
The card as published expires December 31, 2026. Anyone on Medicaid, Medicare, Medigap, TRICARE, VA, or DoD coverage is excluded from both tiers, and so is anyone with no insurance at all. That last point trips people up constantly. If you are uninsured, the card is not your path, LillyDirect self-pay is, and it lands at the same $499.
List price and the pharmacy counter
Lilly’s own pricing page puts the list price of Mounjaro at $1,112.16 per fill, with the wholesale acquisition cost pulled from AnalySource on January 1, 2026 and one fill defined as four pens. List price is what Lilly charges wholesalers, not what you are quoted, but it anchors everything downstream.
At an ordinary pharmacy with no program, SingleCare’s Mounjaro page shows an average retail price of $1,519.20 for four 5 mg pens and a discounted price of $872.48 with its free coupon. So a discount card cuts roughly $650 off the counter price and still costs about $373 more per month than buying direct from Lilly.
What Drives the Price
Which brand your prescription is written for. This is the single biggest lever. Tirzepatide prescribed as Mounjaro self-pays at $499. The same molecule prescribed as Zepbound self-pays at $299 (2.5 mg), $399 (5 mg), or $449 (7.5 mg through 15 mg) through LillyDirect. Zepbound is approved for weight management and Mounjaro for type 2 diabetes, so this is a clinical decision between you and your prescriber, not a shopping choice, but it is worth understanding why the two prices differ.
Whether you buy direct or at a counter. LillyDirect at $499 versus a retail counter at $872 to $1,519 is a $370 to $1,020 monthly swing on the identical product.
Your insurance status, not your income. The $25 price requires commercial coverage that includes Mounjaro. The $499 card tier requires commercial coverage that excludes it. Being uninsured does not unlock a lower tier, and government coverage locks you out of the card entirely.
Dose, but only off-program. LillyDirect charges the same $499 at every strength, so dose escalation does not raise your direct-buy cost. At the counter it does, because retail pricing tracks the strength dispensed.
No generic competition. FDA’s Orange Book lists tirzepatide patents on Mounjaro expiring from May 13, 2036 through December 30, 2041, plus new chemical entity exclusivity through May 13, 2027. No generic tirzepatide is approved, so nothing structural is pushing these prices down except Lilly’s own programs. For the full molecule-level picture across brands, see our guide to tirzepatide cost.
Cash Price vs. Insurance
If you have commercial insurance that covers Mounjaro, use it. The $25 savings-card price beats every cash route by a wide margin, and it is available for up to 13 fills a year.
If your commercial plan excludes Mounjaro, or your deductible has not been met, run the math before you assume insurance wins. The card tier for non-covering commercial plans and the LillyDirect self-pay price both land at $499, so in that situation paying cash is not a penalty, it is simply the price. Patients on high-deductible plans often find $499 direct beats what their plan would charge them pre-deductible.
If you are on Medicare or Medicaid, you cannot use the savings card at all. Your options are your plan’s own formulary coverage or the $499 self-pay route, and self-pay purchases will not count toward your plan’s out-of-pocket maximum.
One more honest note: patient assistance is thinner here than for insulin. Reviewing the Lilly Cares Foundation’s current medication list, Mounjaro is not on it. Lilly Cares covers products including Humalog, Basaglar, Humulin, Lyumjev, Emgality, Taltz, and Verzenio, with income limits of 300% to 500% of the federal poverty level depending on the group, but tirzepatide products are absent as of August 2026.
How to Pay Less
-
Buy through LillyDirect rather than a walk-in counter. At $499 a month it is the cheapest published route for anyone without covering commercial insurance, and it saves $373 to $1,020 a month versus retail.
-
Check the savings card before you assume you do not qualify. If you have any commercial plan, one of the two tiers applies to you. Take two minutes on Lilly’s savings page and answer the attestation questions rather than guessing.
-
Ask about a 3-month fill if you are on the $25 tier. Lilly’s terms allow $25 total for an 84-day, 12-pen prescription. Whether your pharmacy and plan will process it is a separate question, but asking costs nothing.
-
Price the counter anyway with a discount card. If you need a fill today and cannot wait on shipping, compare cards first. Our GoodRx vs. SingleCare comparison explains how the two differ, and SingleCare’s own Mounjaro page currently shows $872.48 versus a $1,519.20 average retail price.
-
Budget the prescribing visit separately. Mounjaro requires an active prescription and periodic follow-up. A free or sliding-scale clinic can handle the visit at low cost if a cash office visit is out of reach, and our fair price checker shows typical cash rates for the office visit itself.
-
Recheck before every refill cycle. GLP-1 cash prices have moved twice since 2024. The federal TrumpRx site currently lists Zepbound at $299 a month against a $1,087 original price, and Lilly has revised its self-pay tiers more than once, so last quarter’s number is not a safe assumption.
Bottom Line
Plan on $499 a month for Mounjaro as a cash payer in August 2026, at any dose, bought direct from Lilly. That is the number to beat, and the only thing that beats it is commercial insurance that actually covers the drug, which brings you to $25.
If you are paying cash mainly for blood sugar control rather than a specific brand, it is worth a conversation about the wider landscape. Our GLP-1 cost guide compares every brand’s self-pay program side by side, and if you also buy diabetes supplies, insulin costs without insurance covers the $35 monthly cap programs that pair with it.